Busca, A <br/><br/>
Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation.  [electronic resource] 

 -  Bone marrow transplantation  May 2000 
 - 1067-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1702410  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adrenal Cortex Hormones--therapeutic use<br/>Bone Marrow Transplantation--adverse effects<br/>Chemical and Drug Induced Liver Injury--etiology<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cyclosporine--therapeutic use<br/>Drug Resistance<br/>Female<br/>Gastrointestinal Diseases--chemically induced<br/>Graft vs Host Disease--drug therapy<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Male<br/>Mycophenolic Acid--adverse effects<br/>Opportunistic Infections--etiology<br/>PUVA Therapy<br/>Prodrugs--therapeutic use<br/>Safety<br/>Transplantation, Homologous--adverse effects<br/>Treatment Outcome